Zimmer Biomet falls after 2025 profit forecast cut

Shares of medical device maker Zimmer Biomet Holdings ZBH.N fall 7.7% to $94.55

ZBH cuts its annual adj. profit forecast to a range of $7.9 to $8.1 per share, compared with previous projected range of $8.15 to $8.35 per share

"Tariffs expected to be a $60 million to $80 million headwind to operating profit in 2025," the company said in a post-earnings call

Co expects majority of tariff impact to be in H2 2025

Expects less than $5 million tariff-related hit in Q2

ZBH expects 2025 revenue growth to be 5.7% to 8.2%, including co's acquisition of orthopedic surgical devices maker Paragon 28 7GQ.F, currency and current tariff impact

Co posts Q1 adj. profit of $1.81 per share, beating analysts' estimate of $1.77 per share, according to data compiled by LSEG

It reports Q1 revenue of $1.91 billion vs estimates of $1.90 billion

As of last close, ZBH has fallen 10.5% YTD